Literature DB >> 19967291

[Breast cancer in Mexico: an urgent priority].

Felicia Marie Knaul1, Gustavo Nigenda, Rafael Lozano, Héctor Arreola-Ornelas, Ana Langer, Julio Frenk.   

Abstract

Breast cancer is a serious threat to the health of women globally and an unrecognized priority in middle-income countries. This paper presents data from Mexico. It shows that breast cancer accounts for more deaths than cervical cancer since 2006. It is the second cause of death among women aged 30 to 54 and affects all socioeconomic groups. Data on detection, although underreported, show 6000 new cases in 1990 and a projected increase to over 16500 per year by 2020. Further, the majority of cases are self-detected and only 10% of all cases are detected in stage I. Mexico s social security systems cover approximately 40 to 45% of the population and include breast cancer treatments. Since 2007 the rest of the population has had the right to breast cancer treatment through Seguro Popular. Despite these entitlements, services are lacking and interventions for early detection, particularly mammography, are very limited. As of 2006 only 22% of women aged 40 to 69 reported having a mammography in the past year. Barriers exist on both the demand and supply sides. Lobbying, education, awareness building and an articulated policy response will be important to ensure extended coverage, access to and acceptance of both treatment and early detection.

Entities:  

Mesh:

Year:  2009        PMID: 19967291     DOI: 10.1590/s0036-36342009000800026

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  18 in total

1.  Breast self-exam and patient interval associate with advanced breast cancer and treatment delay in Mexican women.

Authors:  E Leon-Rodriguez; C Molina-Calzada; M M Rivera-Franco; A Campos-Castro
Journal:  Clin Transl Oncol       Date:  2017-04-25       Impact factor: 3.405

Review 2.  Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal.

Authors:  Subhojit Dey
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  The tetrad BMI, leptin, leptin/adiponectin (L/A) ratio and CA 15-3 are reliable biomarkers of breast cancer.

Authors:  Jonnathan G Santillán-Benítez; Hugo Mendieta-Zerón; Leobardo M Gómez-Oliván; Juan J Torres-Juárez; Juan M González-Bañales; Lorena V Hernández-Peña; Angel Ordóñez-Quiroz
Journal:  J Clin Lab Anal       Date:  2013-01-04       Impact factor: 2.352

4.  Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.

Authors:  Cynthia Villarreal-Garza; Rosa María Alvarez-Gómez; Carlos Pérez-Plasencia; Luis A Herrera; Josef Herzog; Danielle Castillo; Alejandro Mohar; Clementina Castro; Lenny N Gallardo; Dolores Gallardo; Miguel Santibáñez; Kathleen R Blazer; Jeffrey N Weitzel
Journal:  Cancer       Date:  2014-09-18       Impact factor: 6.860

5.  A New Gene Expression Signature for Triple Negative Breast Cancer Using Frozen Fresh Tissue before Neoadjuvant Chemotherapy.

Authors:  Sandra Karina Santuario-Facio; Servando Cardona-Huerta; Yadira Xitlalli Perez-Paramo; Victor Trevino; Francisco Hernandez-Cabrera; Augusto Rojas-Martinez; Grecia Uscanga-Perales; Jorge Luis Martinez-Rodriguez; Lizeth Martinez-Jacobo; Gerardo Padilla-Rivas; Gerardo Muñoz-Maldonado; Juan Francisco Gonzalez-Guerrero; Javier Valero-Gomez; Ana Lorena Vazquez-Guerrero; Herminia Guadalupe Martinez-Rodriguez; Alvaro Barboza-Quintana; Oralia Barboza-Quintana; Raquel Garza-Guajardo; Rocio Ortiz-Lopez
Journal:  Mol Med       Date:  2017-05-04       Impact factor: 6.354

6.  Polymorphisms of the XRCC1 gene and breast cancer risk in the Mexican population.

Authors:  Nelly M Macías-Gómez; Valeria Peralta-Leal; Juan Pablo Meza-Espinoza; Melva Gutiérrez-Angulo; Jorge Durán-González; Juan Manuel Ramírez-González; Alejandra Gaspar-Del Toro; Adolfo Norberto-Rodríguez; Evelia Leal-Ugarte
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

7.  Breast cancer knowledge, attitudes, and early detection practices in United States-Mexico border Latinas.

Authors:  Matthew P Banegas; Yelena Bird; John Moraros; Sasha King; Surasri Prapsiri; Beti Thompson
Journal:  J Womens Health (Larchmt)       Date:  2011-10-04       Impact factor: 2.681

8.  The impact of family history of breast cancer on knowledge, attitudes, and early detection practices of Mexican women along the Mexico-US border.

Authors:  Yelena Bird; Matthew P Banegas; John Moraros; Sasha King; Surasri Prapasiri; Beti Thompson
Journal:  J Immigr Minor Health       Date:  2011-10

9.  Dehydroepiandrosterone inhibits events related with the metastatic process in breast tumor cell lines.

Authors:  Rebeca López-Marure; Estrella Zapata-Gómez; Leticia Rocha-Zavaleta; María Cecilia Aguilar; Magali Espinosa Castilla; Jorge Meléndez Zajgla; Noemí Meraz-Cruz; Claudia Huesca-Gómez; Ricardo Gamboa-Ávila; Erika Olivia Gómez-González
Journal:  Cancer Biol Ther       Date:  2016-06-03       Impact factor: 4.742

10.  Functionalisation of Fe3O4 nanoparticles by 2-((pyrazol-4-yl) methylene) hydrazinecarbothioamide enhances the apoptosis of human breast cancer MCF-7 cells.

Authors:  Mohammad Reza Izadpanah; Ali Salehzadeh; Mohammad Zaefizadeh; Mohammad Nikpasand
Journal:  IET Nanobiotechnol       Date:  2020-08       Impact factor: 1.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.